EMA | Market Exclusive

Home Tags EMA

Analyst Activity – Barclays PLC Raises Its Price Target On Emera...

ME Staff - April 21, 2017 0

Analyst Activity – Wells Fargo & Co Initiates Coverage On Emera...

ME Staff - April 13, 2017 0

Analyst Activity – Royal Bank of Canada Reiterates Outperform on Emera...

ME Staff - March 29, 2017 0

Here’s Why The XBiotech Inc (NASDAQ:XBIT) Data Is So Important

- July 4, 2016 0

Here’s What to Look out for in the XBiotech Inc (NASDAQ:XBIT)...

Roger Hannington - May 25, 2016 0

Is Biogen Inc (NASDAQ:BIIB) and Forward Pharma A/S’ (NASDAQ:FWP) DMF Battle...

Roger Hannington - April 13, 2016 0

Off the Radar Dermira Targets a Billion Dollar Opportunity

Roger Hannington - January 22, 2016 0

Accelerated Assessment Primes Amicus for a Billion Dollar Market

ME Staff - May 27, 2015 0

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 9, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 24, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: EMA

Analyst Activity – Barclays PLC Raises Its Price Target On Emera...

Analyst Activity – Wells Fargo & Co Initiates Coverage On Emera...

Analyst Activity – Royal Bank of Canada Reiterates Outperform on Emera...

Here’s Why The XBiotech Inc (NASDAQ:XBIT) Data Is So Important

Here’s What to Look out for in the XBiotech Inc (NASDAQ:XBIT)...

Is Biogen Inc (NASDAQ:BIIB) and Forward Pharma A/S’ (NASDAQ:FWP) DMF Battle...

Off the Radar Dermira Targets a Billion Dollar Opportunity

Accelerated Assessment Primes Amicus for a Billion Dollar Market

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY